SciVision Biotech Inc
TWSE:1786
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
SciVision Biotech Inc
TWSE:1786
|
TW |
|
W
|
WooDeumGeeFarm Co Ltd
KOSDAQ:403490
|
KR |
|
Literacy Capital PLC
LSE:BOOK
|
UK |
|
S&U PLC
LSE:SUS
|
UK |
|
Quarta-Rad Inc
OTC:QURT
|
US |
|
Powell Industries Inc
NASDAQ:POWL
|
US |
SciVision Biotech Inc
SciVision Biotech, Inc. engages in the research, development, and production of hyaluronic acid medical products. The company is headquartered in Kaohsiung, Kaohsiung. The company went IPO on 2010-12-29. The firm primarily provides subcutaneous fillers for plastic surgery facial injection, joint cavity injections for orthopedics use, as well as hyaluronic acid raw materials, among others. The firm is also involved in deoxyribonucleic acid (DNA) identification, detection, sequencing and application, as well as the manufacturing of care products and foods. The firm operates its business in the Americas, Europe, Asia, Middle East and Africa.
SciVision Biotech, Inc. engages in the research, development, and production of hyaluronic acid medical products. The company is headquartered in Kaohsiung, Kaohsiung. The company went IPO on 2010-12-29. The firm primarily provides subcutaneous fillers for plastic surgery facial injection, joint cavity injections for orthopedics use, as well as hyaluronic acid raw materials, among others. The firm is also involved in deoxyribonucleic acid (DNA) identification, detection, sequencing and application, as well as the manufacturing of care products and foods. The firm operates its business in the Americas, Europe, Asia, Middle East and Africa.
